Investment
Features
FeesSafety
Academy
More
Pluang+

Compare S&P500 ETF (SPY) vs Tilray Brands Inc (TLRY) Price & Performance

S&P500 ETFTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

S&P500 ETF vs Tilray Brands Inc — how do they compare? S&P500 ETF trades at $763.17, while Tilray Brands Inc trades at $4.21 (market cap $577.15M). The key difference: S&P500 ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

SPYTLRY
52-Week High
$777.82$21.00
52-Week Low
$631.99$3.88
Market Cap
$577.15M
Sector
Health
Enterprise Value
$744.29M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

S&P500 ETF

SPY (SPDR S&P 500 ETF) trades at $766.00, down 0.55% with neutral technical signals. The ETF shows mixed sentiment amid geopolitical tensions and AI-driven market concentration risks. Recent news highlights S&P 500 resilience despite oil price surges and Fed rate concerns, with strategists targeting 8,000 levels. A dividend of $1.90 is scheduled for July 2026.

Outlook remains cautiously optimistic with potential for further gains driven by AI productivity and earnings growth, though elevated valuations and Middle East tensions pose near-term volatility risks. Long-term investors may find value in market exposure despite current highs.

Tilray Brands Inc

TLRY trades at $4.30, down 4.44% with a bearish technical outlook. The company reported record fiscal 2026 revenue of $915M but continues to post significant losses with a -13.27% net margin. Recent news highlights expansion in spirits distribution and medical cannabis production, though regulatory uncertainty weighs on sentiment. The stock trades below book value with a P/S of 0.51 and P/B of 0.36, suggesting potential undervaluation despite profitability challenges.

TLRY presents a high-risk opportunity with mixed signals. The discounted valuation and expanding beverage/alcohol business offer upside potential, but persistent losses, negative cash flow, and cannabis regulatory delays create substantial headwinds. Analyst consensus leans cautious with 65% hold ratings, reflecting the stock's speculative nature amid ongoing operational challenges.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

Read more on SPY

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY